Zděblová Čermáková, Z.; Hurník, P.; Konvalinka, D.; Štembírek, J.; Paračková, T.; Resová, K.; Cvek, J.; Blažek, T.; Knybel, L.; Formánek, M.;
et al. HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina 2023, 59, 361.
https://doi.org/10.3390/medicina59020361
AMA Style
Zděblová Čermáková Z, Hurník P, Konvalinka D, Štembírek J, Paračková T, Resová K, Cvek J, Blažek T, Knybel L, Formánek M,
et al. HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina. 2023; 59(2):361.
https://doi.org/10.3390/medicina59020361
Chicago/Turabian Style
Zděblová Čermáková, Zuzana, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukáš Knybel, Martin Formánek,
and et al. 2023. "HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy" Medicina 59, no. 2: 361.
https://doi.org/10.3390/medicina59020361
APA Style
Zděblová Čermáková, Z., Hurník, P., Konvalinka, D., Štembírek, J., Paračková, T., Resová, K., Cvek, J., Blažek, T., Knybel, L., Formánek, M., Gachechiladze, M., Joerger, M., Soltermann, A., Škarda, J., Motyka, O., & Janoutová, J.
(2023). HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy. Medicina, 59(2), 361.
https://doi.org/10.3390/medicina59020361
